Home Featured

Featured

Random

MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion

Hallucinating Long After the Trip is Over: HPPD – Part 2

Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA

MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybin

The Sober Curious: Living Alcohol-Free Is Psychedelic

Opinions | Hallucinations of Meaning: If you can lie, so can...

Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale

Ketamine on the Edge: Mindbloom’s At-Home Injections Spark Debate; UK Eyes...

The View from D.C.: Psychedelic Politics, Blockers and Approvals on the...

Music for Psychedelic Exploration and the First ‘Choose Your Own Adventure’...

Catching Up With the Psychedelic Entourage Effect: Part 5 – MindMed

Numinus Wellness Inc. Announces At-The-Market Offering Equity Program

PT492 – Alien Abductions and Parallel Realities: How Do You Validate...

PT265 – Jessica Cadoch, MA – Cooperation, Drug Exceptionalism, and 12-step...

12 3...321 Page 1 of 321

EDITOR PICKS

Psychedelic Funding Update: Q2 2026

Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic...

Rachel Turetzky, PhD & Douglas S. Wingate, DTCM: The Eight-Circuit Model,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.